Australia - angielski - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - bicalutamide, quantity: 50 mg - tablet, film coated - excipient ingredients: macrogol 400; lactose monohydrate; povidone; titanium dioxide; hypromellose; magnesium stearate; sodium starch glycollate type a - treatment of advanced prostate cancer in combination with lhrh agonist therapy. prevention of disease flare associated with the use of lhrh agonists.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - bicalutamide, quantity: 50 mg - tablet, film coated - excipient ingredients: sodium starch glycollate; magnesium stearate; povidone; lactose monohydrate; titanium dioxide; hypromellose; macrogol 400 - treatment of advanced prostate cancer in combination with lhrh agonist therapy. prevention of disease flare associated with the use of lhrh agonists.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - bicalutamide, quantity: 50 mg - tablet, film coated - excipient ingredients: povidone; lactose monohydrate; sodium starch glycollate type a; magnesium stearate; titanium dioxide; hypromellose; macrogol 400 - treatment of advanced prostate cancer in combination with lhrh agonist therapy.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - bicalutamide, quantity: 50 mg - tablet, film coated - excipient ingredients: povidone; sodium starch glycollate; lactose monohydrate; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; triacetin; macrogol 3350 - treatment of advanced prostate cancer in combination with lhrh agonist therapy.

Izrael - angielski - Ministry of Health

inovamed ltd - bicalutamide - film coated tablets - bicalutamide 150 mg - bicalutamide - bicalutamide - in patients with locally advanced prostate cancer (t3 - t4 any n m0 t1 -t2 n+ m0), bicalutamide 150 mg is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

kremers urban - bicalutamide (unii: a0z3nau9dp) (bicalutamide - unii:a0z3nau9dp) - bicalutamide tablet 50 mg daily is indicated for use in combination therapy with a luteinizing hormone-releasing hormone (lhrh) analog for the treatment of stage d2 metastatic carcinoma of the prostate. bicalutamide tablet 150 mg daily is not approved for use alone or with other treatments [see clinical studies (14.2)  . bicalutamide tablets are contraindicated in any patient who has shown a hypersensitivity reaction to the drug or any of the tablet’s components. hypersensitivity reactions including angioneurotic edema and urticaria have been reported [see adverse reactions (6.2 )  . bicalutamide tablets have no indication for women, and should not be used in this population. bicalutamide tablets may cause fetal harm when administered to a pregnant woman. bicalutamide tablets are contraindicated in women, including those who are or may become pregnant. there are no studies in pregnant women using bicalutamide tablets. if this drug is used during pregnancy, or if the patient becomes pregnant while taking th

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - bicalutamide - film coated tablet - 50 milligram - anti-androgens

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

lexon (uk) ltd - bicalutamide - film-coated tablet - 50 milligram(s) - anti-androgens; bicalutamide

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

lexon pharmaceuticals (ireland) limited - bicalutamide - film-coated tablet - 50 milligram(s) - anti-androgens; bicalutamide

Malta - angielski - Medicines Authority

health house pharma ltd t/as p&d pharmaceuticals ltd 38 woolmer way, bordon, hampshire, gu35 9q, united kingdom - bicalutamide - film-coated tablet - bicalutamide 50 mg - endocrine therapy